Jason Matuszewski

Recent appearances

• 

  New Approaches to Regenerative Therapies in Wound Care with BioStem CEO Jason Matuszewski

  January 28, 2026 · 📺 Xtalks

  In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Jason Matuszewski, chairman, CEO and co-founder of BioStem Technologies, a company developing perinatal tissue allografts for regenerative therapies. The applications of the allografts, developed using the company’s proprietary processing method, include wound care, limb saving in conditions like diabetic foot ulcers and treating wounds and amputations of veterans. After beginning his career as a technical engineer at SC Johnson and later leading process and qu…

  Watch on YouTube ↗

• 

  Jason Matuszewski - CEO, BioStem Technologies - Saving Limbs To Save Lives

  July 29, 2025 · 📺 Progress, Potential, and Possibilities

  Jason Matuszewski is Chief Executive Officer and Chairman of the Board of BioStem Technologies ( https://biostemtechnologies.com/ ), a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. Jason brings a wealth of experience in strategic operations planning and technical projects management from his rigorous technical background. His diverse expertise includes continuous process improvement, training and development programs, regulatory compliance and best practices i…

  Watch on YouTube ↗

• 

  Driving Innovation in Wound Healing: Inside BioStem with Jason Matuszewski

  July 08, 2025 · 📺 Russo Partners

  What happens when an engineer from professional motorsports applies that same precision and drive to regenerative medicine? On this episode of the Russo Edge Podcast, Jason Matuszewski, CEO and Co-founder of BioStem Technologies, a company providing placental tissue products to heal chronic wounds that often defy standard treatment. Jason shares how BioStem’s proprietary BioREtain® technology is helping patients avoid amputations and get back to living. With a scalable manufacturing operation and a mission rooted in compassion and science, BioStem is tackling one of healthcare’s most persis…

  Watch on YouTube ↗

• 

  BioStem Technologies, Inc. CEO Jason Matuszewski, Live from Nasdaq

  April 25, 2025 · 📺 IPO Edge

  Tech Edge hosted a fireside chat on April 22 at Nasdaq MarketSite with Jason Matuszewski, Chief Executive Officer of BioStem Technologies, Inc. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed why the company’s 2024 revenue surged 18x, BioStem's planned NASDAQ uplisting, what makes VENDAJE AC and AmnioWrap2 stand out in the wound care space, and more.

  Watch on YouTube ↗

• 

  No Pretense, Just Purpose: Leading with Heart in Life Sciences with Jason Matuszewski

  April 14, 2025 · 📺 Brilliance Within Coaching

  Welcome back to Conversations Life Science Leaders Aren’t Having. In this episode, we sit down with Jason Matuszewski, CEO of BioStem Technologies, a regenerative medicine company based in South Florida focused on advanced wound care solutions using placental tissue. From the outset, what stands out most about Jason is his authenticity—he leads without pretense and brings a genuine passion for patients, his team, and the broader mission of BioStem. In our conversation, Jason takes us through the winding journey of BioStem’s evolution—from its roots in medical tourism treating high-net-worth in…

  Watch on YouTube ↗

• 

  Sequire Spotlight Presents: Biostem (BSEM) - Harnessing the Natural Properties of Placenta Tissues

  November 20, 2024 · 📺 SEQUIRE

  Host Chris Miglino interviews CEO Jason Matuszewski. He talks about their product, the way that it’s produced, recovered, proccessed, and the way that it supports bodies to recover from wounds.

  Watch on YouTube ↗

• 

  The Shrimp Tank Podcast - Jason Matuszewski & Andrew Van Vurst

  July 10, 2024 · 📺 Shrimp Tank Boca

  🌊🎙️ Dive into today's live Shrimp Tank Podcast at 1 PM! 🎉 We're thrilled to feature Jason Matuszewski, CEO of Biostem Technologies, and Andrew Van Vurst, COO of Biostem Technologies, both leaders in biotech and tissue processing. Don't miss out on their incredible insights and stories. Tune in to catch this dynamic duo! #ShrimpTankPodcast #LivePodcast 📅🕐 Today at 1 PM! 📡💻 Listen live on our platform! @biostem_technologies #BiotechLeaders #JasonMatuszewski #AndrewVanVurst #BiostemTechnologies #PodcastLive #TuneIn

  Watch on YouTube ↗

• 

  #338 - Andrew VanVurst, COO and Jason Matuszewski, CEO at BioStem Technologies

  April 10, 2023 · 📺 Slice of Healthcare Network

  Our Guests: Andrew VanVurst, Co-Founder & COO, and Jason Matuszewski, Co-Founder & CEO at BioStem Technologies What you'll get out of this episode: 📚 Their backgrounds 🧪 An overview of BioStem Technologies 🩹 The cause of complex wounds and how this impacts patients 🤕 Perinatal tissue, and how BioStem Technologies is utilizing this to innovate solutions for complex wound care 👍 The advantages of perinatal tissue-derived allografts as opposed to other treatment options 🔮 What's next? Our sponsors for this episode are Sage Growth Partners & FlipMD Sage Growth Partners accelerates commercial…

  Watch on YouTube ↗

• 

  OTC: $BSEM 💪 Is BioStem Well-Positioned For Wellness & Growth?: Jason Matuszewski, CEO Interview

  January 17, 2023 · 📺 Benzinga Partner Studio

  Is BioStem Technologies, Inc. (OTC: BSEM) well-positioned to positively change lives with their contributions to wellness and healthy recovery? And, consequently, is it possible that they will reap both the intrinsic and financial benefits of their contributions? Hear what BioStem's CEO, Jason Matuszewski, has to say about BioStem's products, contributions, growth, and future prospects in this interview! BioStem Technologies, Inc. (OTC: BSEM) is a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived allografts. Visit BioS…

  Watch on YouTube ↗

• 

  Regenerative Wound Care With BioStem Technologies' Jason Matuszewski & Andrew VanVurst

  September 29, 2022 · 📺 Life Science Connect

  Here's the story of BioStem, its young founders, and how they reached commercial status in short order with a portfolio of proprietary regenerative wound care products developed from perinatal tissue. Fueled by a personal story of resilience and inspiration, Jason Matuszewski (CEO) and Andrew VanVurst (COO) built a company that's developed a local microenvironment activation platform drawing on a combination of small molecules, cytokines, and growth factors to promote tissue repair and regrowth. The company's internal development and cGMP manufacturing facilities have already yielded three app…

  Watch on YouTube ↗

• 

  BioStem Technologies - Innovating in Tissue Regeneration

  August 31, 2022 · 📺 HPR

  Jason Matuszewski, CEO, and Andrew Van Vurst, COO of BioStem Technologies discuss the development, manufacturing, and commercialization of structural tissue allografts derived from perinatal tissues intended for homologous use as a protective covering for soft tissue wounds. By applying the latest research in regenerative medicine, BioStem Technologies has developed BioRetain ®, a unique and proprietary technology for processing and producing advanced tissue allografts. Based on this approach the company has developed three perinatal tissue allograft products for wound care: VENDAJE ®, VENDAJE…

  Watch on YouTube ↗